LB Pharmaceuticals, Inc.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Holding
- Established
- 2015-09-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.lbpharma.us
Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia
- First Posted Date
- 2023-12-21
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- LB Pharmaceuticals Inc.
- Target Recruit Count
- 359
- Registration Number
- NCT06179108
- Locations
- ๐บ๐ธ
Pillar Clinical Research, Richardson, Texas, United States
๐บ๐ธWoodland Internation Research Group, Little Rock, Arkansas, United States
๐บ๐ธWoodland Research Northwest, Rogers, Arkansas, United States
Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2022-05-04
- Lead Sponsor
- LB Pharmaceuticals Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT04588129
- Locations
- ๐บ๐ธ
Washington University School of Medicine, Saint Louis, Missouri, United States
Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults
- First Posted Date
- 2019-12-05
- Last Posted Date
- 2020-12-10
- Lead Sponsor
- LB Pharmaceuticals Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT04187560
- Locations
- ๐บ๐ธ
Medpace Clinical Pharmacology LLC, Cincinnati, Ohio, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath